0      0

EU24CEMAR1/SES207 - Sustainability in Pharma – How to Achieve CO2 Net Zero Goal

‐ Mar 12, 2024 3:00pm

In the realm of sustainability and pharmaceutical innovation, two distinct narratives converge. Through continuous optimization at the Hameln site, Siegfried is pursuing the goal of producing CO2-neutrally by 2024. After 2025 fossil fuels should no longer be used. The CO2 reduction is realized through various projects: purchase of green electricity, purchase of district steam and district heating from waste incineration plants. Reduction of energy consumption in production by actively detecting unnecessary consumption. (e.g. finding compressed air leaks, replacing motors with more efficient types, optimising HVAC systems). Production adjustments were verified before and after the adjustment (e.g. power consumption measurements over a certain period of time) in order to then define additional target values. For further optimization, it is now important to include the machine level in order to identify further levers for a better CO2 balance. The carbon footprint analysis is used to determine the CO2 drivers in production using existing production data (from ongoing operations). The focus of an existing machine is on the optimization of production modes and the possible replacement with more efficient components. As an outlook the analysis shall can also show possible levers like the usage of sustainable produced raw material (scope 3).